Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Vancomycin or Teicoplanin in cSSTI
NCT00430937Phase 3Terminated
- Sponsor
- Novartis
- Start
- Apr 2006
- Primary completion
- Mar 2008
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 3 trial of daptomycin in skin and soft tissue infections (SSTIs), sponsored by Novartis. Started Apr 2006; status: terminated.
02
Drugs
daptomycin
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on NCT00430937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430937.